 WALTHAM, Mass., March 17, 2021 GLOBE NEWSWIRE -- Repligen Corporation NASDAQ:RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 23-24. Tony Hunt, President Chief Executive Officer, will participate in a fireside chat on Wednesday, March 24, at 9:15 a.m. EDT. 